Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis.

Chen, Bao-Ying; Qu, Ping; Tie, Ru; Zhu, Miao-Zhang; Zhu, Xiao-Xing; Yu, Jun

Chen, Bao-Ying; Qu, Ping; Tie, Ru; Zhu, Miao-Zhang; Zhu, Xiao-Xing; Yu, Jun.

Affiliation

Chen BY; Department of Radiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Regul Pept ; 164(2-3): 139-43, 2010 Sep 24.

Article in En | MEDLINE | ID: mdl-20619296

Subject(s)

Atrial Natriuretic Factor/therapeutic use; Carbon Tetrachloride/toxicity; Hepatic Stellate Cells/drug effects; Liver Cirrhosis/chemically induced; Liver Cirrhosis/drug therapy; Animals; Atrial Natriuretic Factor/pharmacology; Carbazoles/pharmacology; Cell Line; Collagen/metabolism; Cyclic GMP/metabolism; Cyclic GMP-Dependent Protein Kinases/antagonists & inhibitors; Cyclic GMP-Dependent Protein Kinases/metabolism; Hepatic Stellate Cells/metabolism; Male; Mice; Mice, Inbred BALB C; Protein Kinase Inhibitors/pharmacology; Rats

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbon Tetrachloride / Atrial Natriuretic Factor / Hepatic Stellate Cells / Liver Cirrhosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Regul Pept Year: 2010 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google